AACE Kumu Papa Aʻo 2020

E kiʻi ʻoe i ka link VIA LIFETIME DOWNLOAD LINK (FAST SPEED) MA hope o ka uku

ʻO ka 2020 virtual-all-virtual Papa Papa AACE Hāʻawi ka moʻo i kahi o 60 mau hola o CME a me MOC kūpono i nā ʻike mai nā alakaʻi alakaʻi ma:

- Lipids a me ke olakino Cardiovascular
- Ka maʻi iwi a me ka maʻi Parathyroid
- Nutr a me ka momona
- Diabetes
- Ka maʻi thyroid
- Pituitary, Gonad, Adrenal a me Neuroendocrine maʻi

Inā ʻoe e hoʻomaka nei i kāu ʻoihana a i ʻole he mau makahiki o ka ʻike, aia i ka papa AACE Master Class kahi mea kūpono a kūpono hoʻi e hoʻoulu ai iā ʻoe. Ke hōʻike nei ka moʻo papa AACE Master Class iā OnDemand, 

Nā Kumuhana A me nā Luna ʻlelo:

Diabetes

- AACE_ACE Comprehensive Type 2 Diabetes Management Algorithm
- Ketoacidosis Diabetes i ka maʻi maʻamau ʻole 1
- Pehea e hoʻonohonoho ai i kahi ʻenehana diabetes a ola i kahi hoʻonohonoho pilikino pilikino-
- Ka mālama ʻana i ka maʻi diabetes ʻelua ma nā ʻōpio ʻōpio - Epidemiology a me nā hana o ka maʻi diabetes Type 2 i waena o nā ʻōpio
- Nā Hana Hou No ka maʻi maʻi maʻi diabetic
- Personalizing Therapies no ka Prevent o ʻAno 1 Diabetes- Ke ʻimi nei i nā endotypes

Thyroid

- ʻO nā palena mua o ka maʻi ʻaʻai thyroid II- Nānā TKI Āhea mākou e hoʻomaka?
- Anaplastic Thyroid Cancer ma 2020 - Ke kuleana e ulu nei o ka Neoadjuvant Therapy a me ke ʻoki kino ʻana no ka maʻi ʻo BRAF-Mutated
- DSN Makahiki i ka loiloi- thyroid DSN
- Maʻi Kupapaʻu i ka Hapai
- Preop Cancer Frontiers- FNA Mutational Data a me ka nui o nā ʻoki ʻana
- Preop Cancer Frontiers II- Medullary Thyroid Cancer - Hiki iā mākou ke nalo?
- ʻO ka thyroid a me ka papaʻai
- thyroid autoimmunity i ka hāpai keiki a me ka Postpartum
- Ultrasound Evaluation a me ka Ikepili o Thyroid Nodules
- Ultrasound Evaluation o Diffuse thyroid Disease a me Thyroiditis
- Ultrasound alakaʻi maikaʻi ʻia ka Needle Needle

iwi

- 2020 AACE Postmenopausal Osteoporosis Nā Kuhi Hana
- Nā Atactical Femur Fractures- Pūnaewele, ʻAno, a me nā Manaʻo Manaʻo
- Fragility iwi ma Type I a me Type II Diabetes
- Ola Iwi i nā maʻi Transgender
- Nā Momi Mīkini ma Hypercalcemia
- DSN Makahiki i ka loiloi - Bone
- FRAX Flaws a me Atlernative Fracture Risk Loiloi i nā pono hana
- ʻIke a me nā hoʻolālā hoʻokele no nā Vertebral Fractures ma ke ʻano he ʻāpana nui i nā Fractures - Pūnaewele, ʻAno, a me nā Manaʻo Manaʻo.
- O Theroporosis Ka Manawa Lōʻihi - Hoʻokiʻi lāʻau a me ka nānā ʻana
- Metabolic & Bariatricʻoki kino- Maikaʻi no ka maʻi diabetes, akā maikaʻi ʻole no nā iwi
- Normocalcemic a me Normohorhormonal Primary Hyperparathyroidism
- Posturgical Hypoparathyroidism- Ka maʻi maʻi a me ka mālama olakino
- Hyperparathyroidism Primer 2020- ʻO ka Parathyroid Glands & maʻi Cardiovascular
- Parathyroidectomy loiloi - Nānā Kuhikuhina o kēia manawa
- Hyperparathyroidism kiʻekiʻe
- Hana ʻoki lāʻau - ʻO ka mea hou loa ma Parathyroid Auto Fluorescence a me ICG Angiography

ʻO Lipids a me Cardiovascular Health

- Lipidology Lapaʻau no ka Endocrinologist
- Lipidology Haumana no ka Endocrinologist - Hoʻolaha Lipid Downing Individualizing
- Ke ʻimi ʻana i ke kinakiona Coronary Artery
- Lipids a me Cardiovascular Health DSN 2020 Makahiki i ka loiloi
- Lipoprotein (a), maʻi Cardiovascular, a me Calcific Aortic Valve Stenosis
- Nonalcoholic Fatty Liver Disease (NAFLD) ma Type 2 Diabetes- Ka manawa no nā Endocrinologists e hana
- Nā maʻi lipid kakaikahi no ka Endocrinologist
- AACE_ACE- 2020 Algorithm no ka mālama ʻana i ka Dyslipidemia a me ka Kāohi ʻana i ka maʻi Cardiovascular

Nutrite a me ka momona

- Hiki i ka ʻenehana ke hoʻomaikaʻi i ke ana o ka meaʻai a me ka hana kino-
- DSN Makahiki i ka loiloi- ʻO ka momona a me ka meaʻai
- E ʻai i ka momona e lilo i kaupaona- ʻo ka Carbohidate Haʻahaʻa, ʻoi loa ka momona momona
- Nā meaʻono a me nā mea momona ʻole
- Nutrite a me ke ola kino Cardiovascular
- Loss Endoscopic Weight Loss a me nā Metabolic Therapies - Nā ʻenehana o kēia wā a me nā wā e hiki mai ana

ʻO Pituitary, Gonad, Adrenal a me Neuroendocrine 

- GHD makua - Nā Kuhi Hou a me Pehea e Hoʻohui ai i ka ʻOihana Lapaʻau
- Nā Bias i ke Kānāwai Lapaʻau- Kūkākūkā me nā hihia kūpono me nā hana kūpono
- DSN Makahiki i ka loiloi- PGAN
- Ka loiloi a me ka mālama ʻana i nā nui Adrenal
- Nā Manaʻo Kūkākūkā Gender ma Acromegaly
- Ke ho'āʻo Laboratory ma Endocrinology- Ke kiʻekiʻe a me nā haʻahaʻa
- Ka mālama ʻana iā Prolactin - a me GH - Hūnā ʻo Adenomas i ka wā o ka hāpai ʻana
- Nā Lapaʻau Lapaʻau no Acromegaly i ka Era o Precision Medicine
- Hyperprolactinemia non-tumoral
- Pheochromocytoma a me Pseudopheochromositosis
- Pituitary Stalk Thickening - Dxential dx a me ka hoʻokele
- Ke kumu no a me ka Progesterone Therapy Pono no Transwomen
- Pono nā kāne ʻelemakule me ka hoʻoliʻiliʻi pili makahiki i nā pae testosterone e loaʻa iā Testosteron Replaced-
- Sodium Perturbations ma hope o ka Pituitaryʻoki kino
- He aha nā mea hou i ka mālama ʻana i nā Tumo Neuroendocrine-

ʻO ka maʻi maʻi momona momona ʻole (NAFLD) i ka manawa maʻi diabetes type 2 no nā endocrinologists e hana

- Nonalcoholic Fatty Liver Disease (NAFLD) ma ka Type 2 Diabetes Time no Endocrinologists e hana

Pono nā kāne ʻelemakule me ka hoʻohālikelike pili i ka makahiki ma nā pae testosterone e loaʻa iā Testoloil Replaced

- Pono nā kāne ʻelemakule me ka hoʻohālikelike pili makahiki i nā pae testosterone e loaʻa iā Testoloil Replaced

Nā Pilikino Pilikino no ka pale ʻana i ka maʻi diabetes 1 e ʻimi nei no nā endotypes

- Personalizing Therapies no ka Kāohi ʻana i ka ʻAno Diabetes ʻimi 1 no nā Endotypes

Nā Hōʻike Hōʻikeʻike Lapaʻau Haumāna

- Diagnostic-pololei-o-DHEAS-i-Mild-Autonomous-Cortisol-Secretion

- Glycemic-Control-In-Patients-Achieving-Diabetes-Remission-With-Weight-Loss-By-Bariatric-Surgery

Nā Hōʻike Hōʻike ʻ Orlelo waha

- Ke ʻae a me ke kūpono o kahi Innovative, Friendly-Friendly, Interactive Technology-Based Lifestyle Intervention no ka Loss Lilo
- ʻO ka paʻakikī Arterial a me Hepatic Fibrosis ma Nash he mea nui kūʻokoʻa, pili pili pili i nā mākua me ka maʻi diabetes Type 2.
- Genetic Predictors o nā ʻokoʻa i ka hoʻomau ʻana o ka Glycemic Curve Parameter i nā mea maʻi me ka maʻi diabetes 2 e loaʻa ana iā Vildagliptin Therapy
- Ka hopena o ka hoʻololi ʻana o ka thyroid Hormone i ka hanana o ka puʻuwai
- ʻO Levoketoconazole i ka mālama ʻia ʻana o ka Endogenous Cushing's Syndrome- ʻO nā hopena o ka loiloi i hoʻonui ʻia o ka Sonics Study.
- Stratification Pilikino no nā mea maʻi me ka Papillary Thyroid Microcarcinoma - Ke aʻo ʻana o Cohort Retrospective
- Hoʻomaʻamaʻa me nā oral Octreotide Capsules i hiki ʻole ke hoʻopili i ka kaohi Glycemic i nā maʻi me ka Acromegaly- Nā hopena mai ka pae 3 Chiasma Optimal Study